Photo by Lukasz Radziejewski on Unsplash 

Some of the stocks that may grab investor focus today are:

• NeuBase Therapeutics, Inc. NBSE +0% reported a net loss of around $25.4 million, or $0.93 per share for the fiscal year ended September 30, 2021, versus a year-ago net loss of around $17.4 million, or $0.89 per share. NeuBase Therapeutics shares gained 0.7% to $3.08 in the after-hours trading session.
• Aeterna Zentaris Inc. AEZS +0% named Giuliano La Fratta as Chief Financial Officer. Aeterna Zentaris shares fell 0.5% to close at $0.4202 on Thursday.
• Ares Management Corporation ARES +0%  said its subsidiary, Ares Holdings L.P., agreed to acquire AMP's PrivateMarketsCo Infrastructure Debt platform for $308 million. Ares Management shares gained 3% to settle at $81.36 on Thursday.
• Escalade, Incorporated ESCA +0% appointed Walter P. Glazer, Jr. as Chief Executive Officer and President. Escalade shares rose 0.6% to close at $15.69 on Thursday.
• The Drugs Controller General of India has given Bharat Biotech’s Covaxin Emergency Use approval in the pediatric age group between 12 and 18 years. Ocugen, Inc. OCGN +0% has the US rights to the Bharat Biotech’s vaccine candidate. Ocugen shares dropped 1.5% to $5.22 in after-hours trading.